Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

128.34
BATS BZX Real-Time Price
As of 10:09am ET
 -2.06 / -1.58%
Today’s Change
110.56
Today|||52-Week Range
205.29
-32.72%
Year-to-Date
3 Health Care Stocks Pushing The Sector Higher
Jul 28 / TheStreet.com - Paid Partner Content
Alexion (ALXN) Q2 Earnings: Stock Likely to Disappoint
Jul 26 / Zacks.com - Paid Partner Content
Alexion (ALXN) Tops Q2 Earnings and Revenues (Revised)
Jul 28 / Zacks.com - Paid Partner Content
I Just Bought These 4 Fast-Growing Biotech Stocks
Jul 23 / MotleyFool.com - Paid Partner Content
Alexion (ALXN) Beats on Q2 Earnings and Revenues
Jul 28 / Zacks.com - Paid Partner Content
3 Stocks Dragging In The Drugs Industry
Jul 22 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Biogen Q2 Results Impress, Gilead HCV Franchise Under Pressure
Jul 27 / Zacks.com - Paid Partner Content
Sorry, You Can't Buy This Hot Biotech -- At Least Not Directly
Jul 21 / MotleyFool.com - Paid Partner Content
Watch for Drug Stocks Earnings on Jul 28: BMY, CELG & More
Jul 27 / Zacks.com - Paid Partner Content
Earnings Estimates for These 3 Biotech Giants Should Be Heading Lower -- Here's Why
Jul 19 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close130.40
Today’s open131.30
Day’s range127.74 - 131.30
Volume23,629
Average volume (3 months)1,835,247
Market cap$29.2B
Dividend yield--
Data as of 10:09am ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)+1.17%
Earnings growth (next 5 years)+23.38%
Revenue growth (last year)+12.25%
P/E ratio196.6
Price/Sales16.57
Price/Book3.56

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.05+0.10%
MYLMylan NV-0.49-1.05%
VRTXVertex Pharmaceutica...-0.41-0.43%
INCYIncyte Corp-0.56-0.64%
Data as of 10:10am ET, 07/29/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
Cheshire, Connecticut

Forecasts

Partner Offers

Search for Jobs